|
1
|
King TE Jr, Pardo A and Selman M:
Idiopathic pulmonary fibrosis. Lancet. 378:1949–1961. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Raghu G, Collard HR, Egan JJ, et al;
ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An
official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis:
evidence-based guidelines for diagnosis and management. Am J Respir
Crit Care Med. 183:788–824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kropski JA, Lawson WE, Young LR and
Blackwell TS: Genetic studies provide clues on the pathogenesis of
idiopathic pulmonary fibrosis. Dis Model Mech. 6:9–17. 2013.
View Article : Google Scholar :
|
|
4
|
Zoz DF, Lawson WE and Blackwell TS:
Idiopathic pulmonary fibrosis: a disorder of epithelial cell
dysfunction. Am J Med Sci. 341:435–438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hardie WD, Hagood JS, Dave V, et al:
Signaling pathways in the epithelial origins of pulmonary fibrosis.
Cell Cycle. 9:2769–2776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakai N and Tager AM: Fibrosis of two:
Epithelial cell-fibroblast interactions in pulmonary fibrosis.
Biochim Biophys Acta. 1832:911–921. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maher TM, Evans IC, Bottoms SE, et al:
Diminished prostaglandin E2 contributes to the apoptosis paradox in
idiopathic pulmonary fibrosis. Am J Respir Crit Care Med.
182:73–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Shu R, Filippatos G and Uhal BD:
Apoptosis in lung injury and remodeling. J Appl Physiol (1985).
97:1535–1542. 2004. View Article : Google Scholar
|
|
9
|
Degryse AL, Tanjore H, Xu XC, et al:
Repetitive intratracheal bleomycin models several features of
idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol.
299:L442–452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Serrano-Mollar A, Nacher M, Gay-Jordi G,
et al: Intratracheal transplantation of alveolar type II cells
reverses bleomycin-induced lung fibrosis. Am J Respir Crit Care
Med. 176:1261–1268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bao S, Wang Y, Sweeney P, et al:
Keratinocyte growth factor induces Akt kinase activity and inhibits
Fas-mediated apoptosis in A549 lung epithelial cells. Am J Physiol
Lung Cell Mol Physiol. 288:L36–L42. 2005. View Article : Google Scholar
|
|
12
|
Crestani B, Marchand-Adam S, Quesnel C, et
al: Hepatocyte growth factor and lung fibrosis. Proc Am Thorac Soc.
9:158–163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Umeda Y, Marui T, Matsuno Y, et al:
Skeletal muscle targeting in vivo electroporation-mediated HGF gene
therapy of bleomycin-induced pulmonary fibrosis in mice. Lab
Invest. 84:836–844. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krause DS, Theise ND, Collector MI, et al:
Multi-organ, multi-lineage engraftment by a single bone
marrow-derived stem cell. Cell. 105:369–377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rejman J, Colombo C and Conese M:
Engraftment of bone marrow-derived stem cells to the lung in a
model of acute respiratory infection by Pseudomonas aeruginosa. Mol
Ther. 17:1257–1265. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fritzell JA Jr, Mao Q, Gundavarapu S, et
al: Fate and effects of adult bone marrow cells in lungs of
normoxic and hyperoxic newborn mice. Am J Respir Cell Mol Biol.
40:575–587. 2009. View Article : Google Scholar :
|
|
17
|
Tzouvelekis A, Ntolios P and Bouros D:
Stem cell treatment for chronic lung diseases. Respiration.
85:179–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Conese M, Carbone A, Castellani S and Di
Gioia S: Paracrine effects and heterogeneity of marrow-derived
stem/progenitor cells: relevance for the treatment of respiratory
diseases. Cells Tissues Organs. 197:445–473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van Poll D, Parekkadan B, Cho CH, et al:
Mesenchymal stem cell-derived molecules directly modulate
hepatocellular death and regeneration in vitro and in vivo.
Hepatology. 47:1634–1643. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu J, Woods CR, Mora AL, et al: Prevention
of endotoxin-induced systemic response by bone marrow-derived
mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol.
293:L131–L141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van Haaften T, Byrne R, Bonnet S, et al:
Airway delivery of mesenchymal stem cells prevents arrested
alveolar growth in neonatal lung injury in rats. Am J Respir Crit
Care Med. 180:1131–1142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tögel F, Weiss K, Yang Y, et al:
Vasculotropic, paracrine actions of infused mesenchymal stem cells
are important to the recovery from acute kidney injury. Am J
Physiol Renal Physiol. 292:F1626–F1635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ashcroft T, Simpson JM and Timbrell V:
Simple method of estimating severity of pulmonary fibrosis on a
numerical scale. J Clin Pathol. 41:467–470. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Phinney DG: Building a consensus regarding
the nature and origin of mesenchymal stem cells. J Cell Biochem
Suppl. 38:7–12. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nauta AJ and Fibbe WE: Immunomodulatory
properties of mesenchymal stromal cells. Blood. 110:3499–3506.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lau AN, Goodwin M, Kim CF and Weiss DJ:
Stem cells and regenerative medicine in lung biology and diseases.
Mol Ther. 20:1116–1130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sadat S, Gehmert S, Song YH, et al: The
cardioprotective effect of mesenchymal stem cells is mediated by
IGF-I and VEGF. Biochem Biophys Res Commun. 363:674–679. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakanishi C, Yamagishi M, Yamahara K, et
al: Activation of cardiac progenitor cells through paracrine
effects of mesenchymal stem cells. Biochem Biophys Res Commun.
374:11–16. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu YX, Chen L, Wang R, et al: Mesenchymal
stem cell therapy for diabetes through paracrine mechanisms. Med
Hypotheses. 71:390–393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gazdhar A, Susuri N, Hostettler K, et al:
HGF expressing stem cells in usual interstitial pneumonia originate
from the bone marrow and are antifibrotic. PLoS One. 8:e654532013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gazdhar A, Temuri A, Knudsen L, et al:
Targeted gene transfer of hepatocyte growth factor to alveolar type
II epithelial cells reduces lung fibrosis in rats. Hum Gene Ther.
24:105–116. 2013. View Article : Google Scholar
|
|
32
|
Chakraborty S, Chopra P, Hak A, Dastidar
SG and Ray A: Hepatocyte growth factor is an attractive target for
the treatment of pulmonary fibrosis. Expert Opin Investig Drugs.
22:499–515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sakamoto S, Yazawa T, Baba Y, et al:
Keratinocyte growth factor gene transduction ameliorates pulmonary
fibrosis induced by bleomycin in mice. Am J Respir Cell Mol Biol.
45:489–497. 2011. View Article : Google Scholar
|
|
34
|
Inghilleri S, Morbini P, Oggionni T, Barni
S and Fenoglio C: In situ assessment of oxidant and nitrogenic
stress in bleomycin pulmonary fibrosis. Histochem Cell Biol.
125:661–669. 2006. View Article : Google Scholar
|
|
35
|
Teixeira KC, Soares FS, Rocha LG, et al:
Attenuation of bleomycin-induced lung injury and oxidative stress
by N-acetylcysteine plus deferoxamine. Pulm Pharmacol Ther.
21:309–316. 2008. View Article : Google Scholar
|
|
36
|
Lanza C, Morando S, Voci A, et al:
Neuroprotective mesenchymal stem cells are endowed with a potent
antioxidant effect in vivo. J Neurochem. 110:1674–1684. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ortiz LA, Gambelli F, McBride C, et al:
Mesenchymal stem cell engraftment in lung is enhanced in response
to bleomycin exposure and ameliorates its fibrotic effects. Proc
Natl Acad Sci USA. 100:8407–8411. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kumamoto M, Nishiwaki T, Matsuo N, Kimura
H and Matsushima K: Minimally cultured bone marrow mesenchymal stem
cells ameliorate fibrotic lung injury. Eur Respir J. 34:740–748.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee SH, Jang AS, Kim YE, et al: Modulation
of cytokine and nitric oxide by mesenchymal stem cell transfer in
lung injury/fibrosis. Respir Res. 11:162010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Moodley Y, Atienza D, Manuelpillai U, et
al: Human umbilical cord mesenchymal stem cells reduce fibrosis of
bleomycin-induced lung injury. Am J Pathol. 175:303–313. 2009.
View Article : Google Scholar : PubMed/NCBI
|
